The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Duvelisib inhibition of chemokines in patients with CLL (DUO study) and iNHL (DYNAMO study).
 
David T. Weaver
Employment - Verastem
 
Kam Sprott
Employment - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
Stock and Other Ownership Interests - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
Consulting or Advisory Role - Infinity Pharmaceuticals; X4 Pharma
Patents, Royalties, Other Intellectual Property - Syros Pharmaceuticals (I)
Travel, Accommodations, Expenses - Smerud Medical Research (I); Syros Pharmaceuticals (I); Verastem
 
Jonathan Pachter
Employment - Verastem
 
Ngocdiep T. Le
Employment - Verastem
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; InCyte; Janssen; MEI Pharma; Merck; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Surface Oncology (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Marco Montillo
No Relationships to Disclose
 
Árpád Illés
Consulting or Advisory Role - Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche; Takeda
 
Gabriel Etienne
No Relationships to Disclose
 
Julio Delgado
No Relationships to Disclose
 
Bryone J. Kuss
No Relationships to Disclose
 
Constantine Tam
No Relationships to Disclose
 
Fritz Offner
No Relationships to Disclose
 
Scott D. Lunin
No Relationships to Disclose
 
Francesc Bosch
No Relationships to Disclose
 
Peter Hillmen
No Relationships to Disclose
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Juno Therapeutics; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); ProNAi (Inst)
 
Stephan Stilgenbauer
No Relationships to Disclose
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Jennifer R. Brown
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; Redx Pharma; Roche/Genentech; Sun Pharma
Research Funding - Gilead Sciences